Old Web
English
Sign In
Acemap
>
authorDetail
>
Xiaoyan Chen
Xiaoyan Chen
National Institutes of Health
Biology
Progeria
Farnesyltransferase inhibitor
Internal medicine
NLS
3
Papers
285
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model (Proceedings of the National Academy of Sciences of the United States of America (2008) 105, (15902-15907) DOI: 10.1073/pnas.0807840105)
2009
Proceedings of the National Academy of Sciences of the United States of America
Brian C. Capell
Michelle Olive
Michael R. Erdos
Kan Cao
Dina A. Faddah
Urraca Tavarez
Karen N. Conneely
Xuan Qu
Hong San
Santhi K. Ganesh
Xiaoyan Chen
Hedwig Avallone
Frank D. Kolodgie
Renu Virmani
Elizabeth G. Nabel
Francis S. Collins
Show All
Source
Cite
Save
Citations (3)
A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model
2008
Proceedings of the National Academy of Sciences of the United States of America
Brian C. Capell
Michelle Olive
Michael R. Erdos
Kan Cao
Dina A. Faddah
Urraca Tavarez
Karen N. Conneely
Xuan Qu
Hong San
Santhi K. Ganesh
Xiaoyan Chen
Hedwig Avallone
Frank D. Kolodgie
Renu Virmani
Elizabeth G. Nabel
Francis S. Collins
Show All
Source
Cite
Save
Citations (180)
Deregulation and mislocalization of the cytokinesis regulator ECT2 activate the Rho signaling pathways leading to malignant transformation
2004
Journal of Biological Chemistry
Shin'ichi Saito
Xiu-fen Liu
Keiju Kamijo
Razi Raziuddin
Takashi Tatsumoto
Isamu Okamoto
Xiaoyan Chen
Chong Chou Lee
Matthew V. Lorenzi
Naoya Ohara
Toru Miki
Show All
Source
Cite
Save
Citations (102)
1